Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel C Kirouac

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
CPT: Pharmacometrics & Systems Pharmacology|May 16, 2018
How Do We "Validate" a QSP Model?Daniel C Kirouac
Clinical Pharmacology and Therapeutics|January 27, 2020
Open Models for Clinical PharmacologyDaniel C Kirouac
Cell Stem Cell|October 23, 2008
The systematic production of cells for cell therapiesDaniel C Kirouac, Peter W Zandstra
Current Opinion in Biotechnology|August 11, 2006
Understanding cellular networks to improve hematopoietic stem cell expansion culturesDaniel C Kirouac, Peter W Zandstra
CPT: Pharmacometrics & Systems Pharmacology|January 31, 2019
Reproducibility of Quantitative Systems Pharmacology Models: Current Challenges and Future OpportunitiesDaniel C Kirouac, Brian Cicali, Stephan Schmidt
NPJ Systems Biology and Applications|March 19, 2024
Making drugs from T cells: The quantitative pharmacology of engineered T cell therapeuticsDaniel C Kirouac, Cole Zmurchok, Denise Morris
Nature Biotechnology|February 28, 2023
Deconvolution of clinical variance in CAR-T cell pharmacology and responseDaniel C Kirouac, Cole Zmurchok, Avisek Deyati, et al.
Nature Biotechnology|May 15, 2023
Author Correction: Deconvolution of clinical variance in CAR-T cell pharmacology and responseDaniel C Kirouac, Cole Zmurchok, Avisek Deyati, et al.
Blood|November 10, 2009
The AC133+CD38-, but not the rhodamine-low, phenotype tracks LTC-IC and SRC function in human cord blood ex vivo expansion culturesCaryn Y Ito, Daniel C Kirouac, Gerard J Madlambayan, et al.
Molecular Systems Biology|July 30, 2009
Cell-cell interaction networks regulate blood stem and progenitor cell fateDaniel C Kirouac, Gerard J Madlambayan, Mei Yu, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
CPT: Pharmacometrics & Systems Pharmacology|May 16, 2018
How Do We "Validate" a QSP Model?Daniel C Kirouac
Clinical Pharmacology and Therapeutics|January 27, 2020
Open Models for Clinical PharmacologyDaniel C Kirouac
Cell Stem Cell|October 23, 2008
The systematic production of cells for cell therapiesDaniel C Kirouac, Peter W Zandstra
Current Opinion in Biotechnology|August 11, 2006
Understanding cellular networks to improve hematopoietic stem cell expansion culturesDaniel C Kirouac, Peter W Zandstra
CPT: Pharmacometrics & Systems Pharmacology|January 31, 2019
Reproducibility of Quantitative Systems Pharmacology Models: Current Challenges and Future OpportunitiesDaniel C Kirouac, Brian Cicali, Stephan Schmidt
NPJ Systems Biology and Applications|March 19, 2024
Making drugs from T cells: The quantitative pharmacology of engineered T cell therapeuticsDaniel C Kirouac, Cole Zmurchok, Denise Morris
Nature Biotechnology|February 28, 2023
Deconvolution of clinical variance in CAR-T cell pharmacology and responseDaniel C Kirouac, Cole Zmurchok, Avisek Deyati, et al.
Nature Biotechnology|May 15, 2023
Author Correction: Deconvolution of clinical variance in CAR-T cell pharmacology and responseDaniel C Kirouac, Cole Zmurchok, Avisek Deyati, et al.
Blood|November 10, 2009
The AC133+CD38-, but not the rhodamine-low, phenotype tracks LTC-IC and SRC function in human cord blood ex vivo expansion culturesCaryn Y Ito, Daniel C Kirouac, Gerard J Madlambayan, et al.
Molecular Systems Biology|July 30, 2009
Cell-cell interaction networks regulate blood stem and progenitor cell fateDaniel C Kirouac, Gerard J Madlambayan, Mei Yu, et al.
Pageof 3